InfuSystem Holdings INFU
NYSE INFU
$12.19 +0.00 (+0.00%)
As of: Aug 20, 2026 · 3:59 PM EDT

InfuSystem Holdings (INFU) Total Non-Current Liabilities (2010 - 2019)

InfuSystem Holdings' (INFU) quarterly Total Non-Current Liabilities came in at $52.1 million in Q2 2019, up 53.89% YoY from $33.9 million in Q2 2018, and up 9.7% on a QoQ basis from $47.5 million in Q1 2019.

InfuSystem Holdings (INFU) Total Non-Current Liabilities (2010 - 2019) Analysis & Trends

InfuSystem Holdings (INFU) has 9 years of Total Non-Current Liabilities data on file, last reported at $52.1 million in Q2 2019.

  • Quarterly Total Non-Current Liabilities rose 53.89% year-over-year to $52.1 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $52.1 million (up 53.89% YoY) and the FY2018 annual result came in at $43.6 million, up 15.04% from the prior year.
  • Total Non-Current Liabilities grew to $52.1 million in Q2 2019, from $47.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $52.1 million in Q2 2019 to a low of $2.1 million in Q1 2017.
  • A 5-year average of $34.1 million and a median of $33.8 million in 2018 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2016 — Total Non-Current Liabilities decreased 1.9% — and 2018, when it soared 1471.9%.
  • Tracing INFU's Total Non-Current Liabilities over 5 years: stood at $29.8 million in 2015, then fell by 1.9% to $29.2 million in 2016, then grew by 29.82% to $37.9 million in 2017, then gained by 15.04% to $43.6 million in 2018, then grew by 19.43% to $52.1 million in 2019.
  • The last three Total Non-Current Liabilities figures came in at $52.1 million (Q2 2019), $47.5 million (Q1 2019), and $43.6 million (Q4 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 21.28 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 9.07 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 3.44 Bn
10 InfuSystem Holdings 244.67 Mn 243.70 Mn 21.41 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2019 52.11 Mn
Mar 31, 2019 47.50 Mn
Dec 31, 2018 43.63 Mn
Sep 30, 2018 43.39 Mn
Jun 30, 2018 33.86 Mn
Mar 31, 2018 33.73 Mn
Dec 31, 2017 37.93 Mn
Sep 30, 2017 26.64 Mn
Jun 30, 2017 29.02 Mn
Mar 31, 2017 2.15 Mn
Dec 31, 2016 29.22 Mn
Dec 31, 2015 29.78 Mn
Sep 30, 2013 34.77 Mn
Jun 30, 2013 34.94 Mn
Mar 31, 2013 35.70 Mn
Dec 31, 2012 37.51 Mn
Mar 31, 2012 35.62 Mn
Dec 31, 2011 35.68 Mn
Sep 30, 2011 38.36 Mn
Jun 30, 2011 36.01 Mn